NARF-AS1

Across TCGA pan-cancer cohorts, NARF-AS1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated NARF-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher NARF-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NARF-AS1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

KIRC, HNSC, and SKCM are the cancer types where NARF-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.584	0.754	<.001	72	view →
HNSC	OS	Quartile	All	0.574	0.300	.002	72	view →
SKCM	DFS	Quartile	III,IV	0.664	0.297	<.001	43	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
ACC	DFS	Quartile	All	0.270	0.719	.003	26	view →
UVM	DFS	Quartile	III,IV	0.374	0.857	.012	25	view →
LGG	DFS	Tertile	All	0.770	0.879	<.001	25	view →
BLCA	OS	Tertile	All	0.523	0.241	.004	18	view →
DLBC	DFS	Quartile	All	0.414	0.910	.007	12	view →
LAML	DFS	Quartile	All	0.822	0.356	.002	12	view →
THCA	DFS	Tertile	IV	0.402	0.799	.013	10	view →
READ	OS	Median	All	0.852	0.322	.003	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

NARF-AS1–KIRC (OS)

Open the KIRC breakdown →